SCHEMBL257751

SCHEMBL257751

CC(F)(F)C(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.55
MAPT P10636 3/20 0.55
CES1 P23141 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.50
HPGD P15428 2/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
CYP2C9 P11712 1/20 0.47
RXRA P19793 1/20 0.46
RXRB P28702 1/20 0.46
ALDH1A1 P00352 2/20 0.46
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46
KDM4E B2RXH2 1/20 0.46
USP2 O75604 1/20 0.46
PTPN1 P18031 1/20 0.46
GSK3B P49841 1/20 0.46
FASN P49327 1/20 0.45
PTPN5 P54829 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL633283 0.87 CES1 (0.67) MAPTCES1L3MBTL1ALDH1A1
SCHEMBL29242313 0.84 SMN1; SMN2 (0.55) SMN1; SMN2MAPTCES1L3MBTL1HPGD
SCHEMBL4502846 0.83 CES1 (0.75) SMN1; SMN2MAPTCES1L3MBTL1RAB9A
SCHEMBL8237871 0.83 SMN1; SMN2 (0.59) SMN1; SMN2MAPTL3MBTL1HPGDRAB9A
SCHEMBL13246765 0.83 SMN1; SMN2 (0.59) SMN1; SMN2MAPTL3MBTL1HPGDRAB9A
SCHEMBL10711163 0.82 SMN1; SMN2 (0.57) SMN1; SMN2MAPTL3MBTL1HPGDRAB9A
SCHEMBL6469949 0.80 SMN1; SMN2 (0.55) SMN1; SMN2MAPTL3MBTL1HPGDRAB9A
SCHEMBL28523787 0.80 SMN1; SMN2 (0.55) SMN1; SMN2MAPTCES1L3MBTL1HPGD
SCHEMBL29242363 0.80 SMN1; SMN2 (0.55) SMN1; SMN2MAPTL3MBTL1HPGDRAB9A
SCHEMBL8995326 0.78 SMN1; SMN2 (0.53) SMN1; SMN2MAPTL3MBTL1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2399585-A1 Boronic acids and esters as inhibitors of fatty acid amide hydrolase Infinity Pharmaceuticals, Inc. (US) 2011-12-28 EP disclosed